Cerity Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Sell
69,097
-1,335
-2% -$7.16K ﹤0.01% 2708
2026
Q1
$380K Buy
70,432
+254
+0.4% +$1.52K ﹤0.01% 2451
2025
Q4
$488K Sell
70,178
-677
-1% -$4.45K ﹤0.01% 2126
2025
Q3
$457K Sell
70,855
-1,425
-2% -$9.74K ﹤0.01% 2035
2025
Q2
$481K Sell
72,280
-1,255
-2% -$6.45K ﹤0.01% 1883
2025
Q1
$476K Sell
73,535
-5,325
-7% -$38.3K ﹤0.01% 1779
2024
Q4
$643K Sell
78,860
-430
-0.5% -$3.54K ﹤0.01% 1626
2024
Q3
$647K Buy
79,290
+9,978
+14% +$65.8K ﹤0.01% 1634
2024
Q2
$483K Sell
69,312
-21,876
-24% -$166K ﹤0.01% 1556
2024
Q1
$968K Buy
+91,188
New +$797K ﹤0.01% 1295

Other funds holding BHC

Cerity Partners's BHC Position: Q2 2026 in Review

Cerity Partners reduced its Bausch Health (BHC) stake by 1.9% in Q2 2026, selling an estimated $7.16K and leaving 69,097 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #2708.

Cerity Partners first reported a position in BHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $968K in Q1 2024. 212 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Cerity Partners held 69,097 shares of Bausch Health worth $341K as of Q2 2026.
  • Cerity Partners sold 1,335 Bausch Health shares in Q2 2026, an estimated $7.16K.
  • Bausch Health made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2708 holding.
  • Cerity Partners first reported a position in Bausch Health in Q1 2024 and has held it in 10 quarters since.
  • Cerity Partners's Bausch Health position peaked at $968K in Q1 2024.
  • 212 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.